In July 2014 Public Health England opened a consultation into whether the current 'Drug misuse and dependence: UK guidelines on clinical management', known to many in the field as the 'Orange Guidelines', should be reviewed. Release's position is that the Guidelines should not be subject to review. The Guidelines are still sufficient and reflect good clinical practice. More importantly, the political environment could result in any review being subject to interference and could lead to the final document being one that is focused on the ideological principle of 'recovery' rather than evidence based treatment interventions. Read Release's full response on why there is a risk of the process being politicised.
- Drugs & The Law
- About us